Product Code: 978-1-68038-500-7
Facial Implants Market Growth & Trends
The global facial implants market size is expected to reach USD 5.06 billion by 2030, growing at a CAGR of 8.5% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing incidences of facial injuries, demand for non-surgical facial rejuvenation surgery, and the introduction of technologically advanced 3D printed implants for facial reconstruction are expected to drive the industry over the forecast period. In addition, the rising initiatives in a probe to increase awareness regarding aesthetic surgery are expected to drive industry growth in the near future. For instance, The American Society of Plastic Surgeons (ASPS) supports, educates, and advocates improved patient care & work toward enhancing awareness about aesthetics in the U.S.
It also conducts periodic medical conferences, thereby educating surgeons on the latest techniques in the field of cosmetic surgery. Furthermore, the growing geriatric population and adoption of cosmetic procedures are some of the factors contributing to the growth of the market. North America was the largest regional market and was estimated at over USD 944.1 million in 2022. The region's market position is attributed to factors, such as the increased expenditure on aesthetic procedures, high awareness about facial rejuvenation surgery, and the presence of sophisticated healthcare infrastructure.
Facial Implants Market Report Highlights
- Global industry growth is attributed to factors, such as the growing demand for minimally invasive surgery and the prevalence of target disorders
- The eyelid surgery procedure segment led the market in 2022 owing to the increasing demand for blepharoplasty procedures for the treatment of puffy eyelids, excessive fats reduction & vision correction
- Chin and mandibular implants dominated the product segment with a share of over 30.3% in 2022 owing to the increasing volume of reconstructive chin augmentation procedures
- The injectables segment is expected to witness significant growth over the forecast period due to the growing demand for minimally invasive facial reconstruction surgeries
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Market Definitions
- 1.2. Regional Scope
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
- 1.6. Information Analysis
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Data Visualization
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Trends and Outlook
- 3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.2. Market Restraint Analysis
- 3.4. Business Environment Analysis
- 3.4.1. PESTLE Analysis
- 3.4.2. Porter's Five Forces Analysis
- 3.5. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
- 4.1. Facial Implant Market: Product Movement Analysis, 2022 & 2030
- 4.2. Chin and Mandibular
- 4.2.1. Chin and Mandibular Market, 2018 - 2030 (USD Million)
- 4.3. Cheek
- 4.3.1. Cheek Market, 2018 - 2030 (USD Million)
- 4.4. Nasal
- 4.4.1. Nasal Market, 2018 - 2030 (USD Million)
- 4.5. Injectables
- 4.5.1. Injectables Market, 2018 - 2030 (USD Million)
Chapter 5. Material Business Analysis
- 5.1. Facial Implant Market: Material Movement Analysis, 2022 & 2030
- 5.2. Metal
- 5.2.1. Metal Market, 2018 - 2030 (USD Million)
- 5.3. Biologicals
- 5.3.1. Biologicals Market, 2018 - 2030 (USD Million)
- 5.4. Polymers
- 5.4.1. Polymers Market, 2018 - 2030 (USD Million)
- 5.5. Ceramic
- 5.5.1. Ceramic Market, 2018 - 2030 (USD Million)
Chapter 6. Procedure Business Analysis
- 6.1. Facial Implant Market: Procedure Movement Analysis, 2022 & 2030
- 6.2. Eyelid Surgery
- 6.2.1. Eyelid Surgery Market, 2018 - 2030 (USD Million)
- 6.3. Facelift
- 6.3.1. Facelift Market, 2018 - 2030 (USD Million)
- 6.4. Rhinoplasty
- 6.4.1. Rhinoplasty Market, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
- 7.1. Regional Market Snapshot
- 7.2. North America
- 7.2.1. North America Facial Implant Market, 2018 - 2030 (USD Million)
- 7.2.2. U.S.
- 7.2.2.1. U.S. Facial Implant Market, 2018 - 2030 (USD Million)
- 7.2.2.2. Key Country Dynamics
- 7.2.2.3. Regulatory Framework
- 7.2.2.4. Competitive Scenario
- 7.2.3. Canada
- 7.2.3.1. Canada Facial Implant Market, 2018 - 2030 (USD Million)
- 7.2.3.2. Key Country Dynamics
- 7.2.3.3. Regulatory Framework
- 7.2.3.4. Competitive Scenario
- 7.3. Europe
- 7.3.1. Europe Facial Implant Market, 2018 - 2030 (USD Million)
- 7.3.2. Germany
- 7.3.2.1. Germany Facial Implant Market, 2018 - 2030 (USD Million)
- 7.3.2.2. Key Country Dynamics
- 7.3.2.3. Regulatory Framework
- 7.3.2.4. Competitive Scenario
- 7.3.3. UK
- 7.3.3.1. UK Facial Implant Market, 2018 - 2030 (USD Million)
- 7.3.3.2. Key Country Dynamics
- 7.3.3.3. Regulatory Framework
- 7.3.3.4. Competitive Scenario
- 7.3.4. France
- 7.3.4.1. France Facial Implant Market, 2018 - 2030 (USD Million)
- 7.3.4.2. Key Country Dynamics
- 7.3.4.3. Regulatory Framework
- 7.3.4.4. Competitive Scenario
- 7.3.5. Italy
- 7.3.5.1. Italy Facial Implant Market, 2018 - 2030 (USD Million)
- 7.3.5.2. Key Country Dynamics
- 7.3.5.3. Regulatory Framework
- 7.3.5.4. Competitive Scenario
- 7.3.6. Spain
- 7.3.6.1. Spain Facial Implant Market, 2018 - 2030 (USD Million)
- 7.3.6.2. Key Country Dynamics
- 7.3.6.3. Regulatory Framework
- 7.3.6.4. Competitive Scenario
- 7.3.7. Denmark
- 7.3.7.1. Denmark Facial Implant Market, 2018 - 2030 (USD Million)
- 7.3.7.2. Key Country Dynamics
- 7.3.7.3. Regulatory Framework
- 7.3.7.4. Competitive Scenario
- 7.3.8. Sweden
- 7.3.8.1. Sweden Facial Implant Market, 2018 - 2030 (USD Million)
- 7.3.8.2. Key Country Dynamics
- 7.3.8.3. Regulatory Framework
- 7.3.8.4. Competitive Scenario
- 7.3.9. Norway
- 7.3.9.1. Norway Facial Implant Market, 2018 - 2030 (USD Million)
- 7.3.9.2. Key Country Dynamics
- 7.3.9.3. Regulatory Framework
- 7.3.9.4. Competitive Scenario
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Facial Implant Market, 2018 - 2030 (USD Million)
- 7.4.2. Japan
- 7.4.2.1. Japan Facial Implant Market, 2018 - 2030 (USD Million)
- 7.4.2.2. Key Country Dynamics
- 7.4.2.3. Regulatory Framework
- 7.4.2.4. Competitive Scenario
- 7.4.3. China
- 7.4.3.1. China Facial Implant Market, 2018 - 2030 (USD Million)
- 7.4.3.2. Key Country Dynamics
- 7.4.3.3. Regulatory Framework
- 7.4.3.4. Competitive Scenario
- 7.4.4. India
- 7.4.4.1. India Facial Implant Market, 2018 - 2030 (USD Million)
- 7.4.4.2. Key Country Dynamics
- 7.4.4.3. Regulatory Framework
- 7.4.4.4. Competitive Scenario
- 7.4.5. South Korea
- 7.4.5.1. South Korea Facial Implant Market, 2018 - 2030 (USD Million)
- 7.4.5.2. Key Country Dynamics
- 7.4.5.3. Regulatory Framework
- 7.4.5.4. Competitive Scenario
- 7.4.6. Australia
- 7.4.6.1. Australia Facial Implant Market, 2018 - 2030 (USD Million)
- 7.4.6.2. Key Country Dynamics
- 7.4.6.3. Regulatory Framework
- 7.4.6.4. Competitive Scenario
- 7.4.7. Thailand
- 7.4.7.1. Thailand Facial Implant Market, 2018 - 2030 (USD Million)
- 7.4.7.2. Key Country Dynamics
- 7.4.7.3. Regulatory Framework
- 7.4.7.4. Competitive Scenario
- 7.5. Latin America
- 7.5.1. Latin America Facial Implant Market, 2018 - 2030 (USD Million)
- 7.5.2. Key Country Dynamics
- 7.5.3. Regulatory Framework
- 7.5.4. Competitive Scenario
- 7.5.5. Brazil
- 7.5.5.1. Brazil Facial Implant Market, 2018 - 2030 (USD Million)
- 7.5.5.2. Key Country Dynamics
- 7.5.5.3. Regulatory Framework
- 7.5.5.4. Competitive Scenario
- 7.5.6. Mexico
- 7.5.6.1. Mexico Facial Implant Market, 2018 - 2030 (USD Million)
- 7.5.6.2. Key Country Dynamics
- 7.5.6.3. Regulatory Framework
- 7.5.6.4. Competitive Scenario
- 7.5.7. Argentina
- 7.5.7.1. Argentina Facial Implant Market, 2018 - 2030 (USD Million)
- 7.5.7.2. Key Country Dynamics
- 7.5.7.3. Regulatory Framework
- 7.5.7.4. Competitive Scenario
- 7.6. MEA
- 7.6.1. MEA Facial Implant Market, 2018 - 2030 (USD Million)
- 7.6.2. South Africa
- 7.6.2.1. South Africa Facial Implant Market, 2018 - 2030 (USD Million)
- 7.6.2.2. Key Country Dynamics
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Competitive Scenario
- 7.6.3. Saudi Arabia
- 7.6.3.1. Saudi Arabia Facial Implant Market, 2018 - 2030 (USD Million)
- 7.6.3.2. Key Country Dynamics
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Competitive Scenario
- 7.6.4. UAE
- 7.6.4.1. UAE Facial Implant Market, 2018 - 2030 (USD Million)
- 7.6.4.2. Key Country Dynamics
- 7.6.4.3. Regulatory Framework
- 7.6.4.4. Competitive Scenario
- 7.6.5. Kuwait
- 7.6.5.1. Kuwait Facial Implant Market, 2018 - 2030 (USD Million)
- 7.6.5.2. Key Country Dynamics
- 7.6.5.3. Regulatory Framework
- 7.6.5.4. Competitive Scenario
Chapter 8. Competitive Landscape
- 8.1. Company Categorization
- 8.2. Strategy Mapping
- 8.2.1. Acquisition
- 8.2.2. Collaborations
- 8.2.3. New Platform Launches
- 8.2.4. Others
- 8.3. Company Profiles/Listing
- 8.3.1. Zimmer Biomet
- 8.3.1.1. Company Overview
- 8.3.1.2. Financial Performance
- 8.3.1.3. Platform Benchmarking
- 8.3.1.4. Strategic Initiatives
- 8.3.2. Depuy Synthes
- 8.3.2.1. Company Overview
- 8.3.2.2. Financial Performance
- 8.3.2.3. Platform Benchmarking
- 8.3.2.4. Strategic Initiatives
- 8.3.3. Stryker
- 8.3.3.1. Company Overview
- 8.3.3.2. Financial Performance
- 8.3.3.3. Platform Benchmarking
- 8.3.3.4. Strategic Initiatives
- 8.3.4. Medartis AG
- 8.3.4.1. Company Overview
- 8.3.4.2. Financial Performance
- 8.3.4.3. Platform Benchmarking
- 8.3.4.4. Strategic Initiatives
- 8.3.5. EUROS; Xilloc
- 8.3.5.1. Company Overview
- 8.3.5.2. Financial Performance
- 8.3.5.3. Platform Benchmarking
- 8.3.5.4. Strategic Initiatives
- 8.3.6. KLS Martin Group
- 8.3.6.1. Company Overview
- 8.3.6.2. Financial Performance
- 8.3.6.3. Platform Benchmarking
- 8.3.6.4. Strategic Initiatives
- 8.3.7. Hanson Medical, Inc
- 8.3.7.1. Company Overview
- 8.3.7.2. Financial Performance
- 8.3.7.3. Platform Benchmarking
- 8.3.7.4. Strategic Initiatives
- 8.3.8. Integra Life Sciences
- 8.3.8.1. Company Overview
- 8.3.8.2. Financial Performance
- 8.3.8.3. Platform Benchmarking
- 8.3.8.4. Strategic Initiatives
- 8.3.9. OsteoMed
- 8.3.9.1. Company Overview
- 8.3.9.2. Financial Performance
- 8.3.9.3. Platform Benchmarking
- 8.3.9.4. Strategic Initiatives
- 8.3.10. Sientra Inc
- 8.3.10.1. Company Overview
- 8.3.10.2. Financial Performance
- 8.3.10.3. Platform Benchmarking
- 8.3.10.4. Strategic Initiatives